Ajani, J A <br/><br/>
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 1988 
 - 1703-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1988.6.11.1703  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Clinical Trials as Topic<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Ifosfamide--adverse effects<br/>Male<br/>Mercaptoethanol--analogs & derivatives<br/>Mesna--adverse effects<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy